Chronic hepatitis B infections on the rise since 2008
In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.
It is always time to test: Spring European Testing Week
In order to maximise the benefits of treatment for HIV or viral hepatitis, it is critical to test and diagnose people as soon as possible in the course of the infection. ECDC supports this objective of European Testing Week.
Gonorrhoea cases on the rise across Europe
Following a decline in notification rates in 2016, the number of gonorrhoea cases has gone up by 17% across the reporting EU/EEA countries with more than 89 000 confirmed diagnoses in 2017 – more than 240 cases a day.
Cyclone Idai: ECDC joins emergency response as more cases of cholera and waterborne diseases expected
ECDC has deployed an epidemiologist under the EU Civil Protection Mechanism to assist in the emergency response in Mozambique. The mission will support the humanitarian response with public health assessments and epidemiological advice. ECDC is also producing a risk assessment on the health risks related to this event.
Whole genome sequencing: new ECDC framework suggests priority diseases and implementation options
Whole genome sequencing (WGS) is a fast-moving technology, but the pace of change vary between pathogens/diseases and European Union countries. In a new report, ECDC proposes to prioritise the implementation of WGS depending on disease and public health application.
Strong laboratory leaders - a key asset for global disease control
Laboratories play an essential role in the detection, diagnosis, prevention and control of diseases. To strengthen this role, ECDC and five partner organisations have developed the Global Laboratory Leadership Programme (GLLP) to support and sustain national laboratory systems under a One Health approach.
Will tuberculosis be the next disease to be eliminated in Europe?
It should be. Despite being a curable disease, tuberculosis (TB) is still a challenging public health issue in the European Union and European Economic Area (EU/EEA), with over 55 000 TB infections reported annually and thousands of fatalities.
ECDC launches e-learning course and operational tool for development of rapid risk assessments
ECDC launches a new e-learning course on rapid risk assessments (RRA) as well as an operational tool that describes the RRA methodology used by the Centre. The course and the tool support public health experts responsible for developing RRAs at European, national or sub-national level.